We are live on ! Find out more
MREO

Mereo BioPharma
MREO

64 hedge funds and large institutions have $182M invested in Mereo BioPharma in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,970% more call options, than puts

Call options by funds: $2.21M | Put options by funds: $107K

101% more capital invested

Capital invested by funds: $90.4M → $182M (+$91.2M)

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

14% more funds holding

Funds holding: 56 → 64 (+8)

1.15% more ownership

Funds ownership: 10.06% → 11.21% (+1.2%)

Holders
64
Holders Change
+8
Holders Change %
+14.29%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
17
Increased
19
Reduced
13
Closed
9
Calls
$2.21M
Puts
$107K
Net Calls
+$2.11M
Net Calls Change
+$1.45M

Top Buyers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
+$6.16M
2
RCMNY
Rubric Capital Management (New York)
New York
+$3.7M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.54M
4
Aberdeen Group
Aberdeen Group
United Kingdom
+$2.97M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$956K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$3.67M
2
JGC
J. Goldman & Co
New York
-$542K
3
FAM
Formidable Asset Management
Ohio
-$428K
4
DCM
DAFNA Capital Management
California
-$351K
5
JP Morgan Chase
JP Morgan Chase
New York
-$217K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$223K – – –
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$144K +$120K +62,843 New
HSBC Holdings
28
HSBC Holdings
United Kingdom
$134K – – –
Primecap Management
29
Primecap Management
California
$125K -$47.8K -25,000 -32%
SSA
30
Schonfeld Strategic Advisors
New York
$116K -$154K -80,500 -62%
Envestnet Asset Management
31
Envestnet Asset Management
Illinois
$109K +$90.2K +47,169 New
CHAM
32
Clear Harbor Asset Management
Connecticut
$108K -$7.65K -4,000 -6%
FA
33
Forefront Analytics
Pennsylvania
$83.4K -$56.5K -29,525 -45%
Qube Research & Technologies (QRT)
34
Qube Research & Technologies (QRT)
United Kingdom
$74.3K +$61.5K +32,160 New
PI
35
PFG Investments
New York
$69.3K – – –
CC
36
Centiva Capital
New York
$57.8K – – –
LCM
37
Lynwood Capital Management
Ontario, Canada
$57.8K +$47.8K +25,000 New
VF
38
Virtu Financial
New York
$47K -$26.3K -13,771 -40%
GSEP
39
Golden State Equity Partners
California
$46.9K +$11.3K +5,900 +41%
LFAS
40
Level Four Advisory Services
Texas
$46.2K – – –
JP Morgan Chase
41
JP Morgan Chase
New York
$44.2K -$217K -113,683 -86%
OIA
42
OneDigital Investment Advisors
Kansas
$43.7K -$14.2K -7,398 -28%
Marshall Wace
43
Marshall Wace
United Kingdom
$34.4K +$28.5K +14,883 New
CSS
44
Cubist Systematic Strategies
Connecticut
$33.9K +$28.1K +14,686 New
SRL
45
Scientech Research LLC
New Jersey
$32.2K +$26.7K +13,955 New
NFSG
46
Newbridge Financial Services Group
Florida
$21.9K +$18.2K +9,500 New
GI
47
GAMMA Investing
California
$17.5K +$8.82K +4,612 New
BlackRock
48
BlackRock
New York
$13.7K +$11.3K +5,932 New
AAP
49
Arax Advisory Partners
Colorado
$9.24K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$9.03K +$595 +311 +9%
1
2
3

MREO Hedge Fund Activity: Q4 2023 in Review

64 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Mereo BioPharma (MREO) for Q4 2023, worth a combined $182M — up 101% from $90.4M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MREO positions and 9 closed out — a net gain of 8 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Mangrove Partners, adding an estimated $6.16M. The largest seller was Citadel Advisors, cutting an estimated $3.67M.

  • 64 institutional investors held Mereo BioPharma (MREO) as of Q4 2023, up from 56 in Q3 2023.
  • Funds reported $182M of Mereo BioPharma stock for Q4 2023, up 101% quarter-over-quarter.
  • 17 funds opened new Mereo BioPharma positions in Q4 2023 and 9 closed out, a net change of +8 holders.
  • The largest Mereo BioPharma buyer in Q4 2023 was Mangrove Partners, an estimated $6.16M added.
  • The largest Mereo BioPharma seller in Q4 2023 was Citadel Advisors, an estimated $3.67M sold.

Based on aggregated 13F filings for Q4 2023.